Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 232

1.

Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection.

Sabharwal H, Michon F, Nelson D, Dong W, Fuchs K, Manjarrez RC, Sarkar A, Uitz C, Viteri-Jackson A, Suarez RS, Blake M, Zabriskie JB.

J Infect Dis. 2006 Jan 1;193(1):129-35. Epub 2005 Nov 29.

PMID:
16323141
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice.

Okamoto S, Tamura Y, Terao Y, Hamada S, Kawabata S.

Vaccine. 2005 Sep 23;23(40):4852-9.

PMID:
15990202
[PubMed - indexed for MEDLINE]
4.

Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.

Olive C, Ho MF, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF.

J Infect Dis. 2006 Jun 15;193(12):1666-76. Epub 2006 May 10.

PMID:
16703510
[PubMed - indexed for MEDLINE]
Free Article
5.

Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

Wessels MR, Paoletti LC, Pinel J, Kasper DL.

J Infect Dis. 1995 Apr;171(4):879-84.

PMID:
7706814
[PubMed - indexed for MEDLINE]
6.

Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults.

Baker CJ, Rench MA, Paoletti LC, Edwards MS.

Vaccine. 2007 Jan 2;25(1):55-63. Epub 2006 Jul 31.

PMID:
16919857
[PubMed - indexed for MEDLINE]
7.

Phagocytic, serological, and protective properties of streptococcal group A carbohydrate antibodies.

Zabriskie JB, Poon-King T, Blake MS, Michon F, Yoshinaga M.

Adv Exp Med Biol. 1997;418:917-9.

PMID:
9331798
[PubMed - indexed for MEDLINE]
8.

Similar ability of FbaA with M protein to elicit protective immunity against group A streptococcus challenge in mice.

Ma CQ, Li CH, Wang XR, Zeng RH, Yin XL, Feng HD, Wei L.

Cell Mol Immunol. 2009 Feb;6(1):73-7. doi: 10.1038/cmi.2009.10.

PMID:
19254483
[PubMed - indexed for MEDLINE]
Free Article
9.

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

Hall MA, Stroop SD, Hu MC, Walls MA, Reddish MA, Burt DS, Lowell GH, Dale JB.

Infect Immun. 2004 May;72(5):2507-12.

PMID:
15102757
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.

Huang YS, Fisher M, Nasrawi Z, Eichenbaum Z.

J Infect Dis. 2011 Jun 1;203(11):1595-601. doi: 10.1093/infdis/jir149.

PMID:
21592989
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.

Vohra H, Dey N, Gupta S, Sharma AK, Kumar R, McMillan D, Good MF.

Res Microbiol. 2005 May;156(4):575-82. Epub 2005 Feb 19.

PMID:
15862457
[PubMed - indexed for MEDLINE]
12.

Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.

Olive C, Sun HK, Ho MF, Dyer J, Horváth A, Toth I, Good MF.

J Infect Dis. 2006 Aug 1;194(3):316-24. Epub 2006 Jun 30.

PMID:
16826479
[PubMed - indexed for MEDLINE]
Free Article
14.

Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.

Palazzi DL, Rench MA, Edwards MS, Baker CJ.

J Infect Dis. 2004 Aug 1;190(3):558-64. Epub 2004 Jun 30.

PMID:
15243932
[PubMed - indexed for MEDLINE]
Free Article
15.

Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus.

Batzloff MR, Yan H, Davies MR, Hartas J, Lowell GH, White G, Burt DS, Leanderson T, Good MF.

J Infect Dis. 2005 Oct 15;192(8):1450-5. Epub 2005 Sep 9.

PMID:
16170764
[PubMed - indexed for MEDLINE]
Free Article
16.

Active and passive immunizations with the streptococcal esterase Sse protect mice against subcutaneous infection with group A streptococci.

Liu M, Zhu H, Zhang J, Lei B.

Infect Immun. 2007 Jul;75(7):3651-7. Epub 2007 May 14.

PMID:
17502395
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.

Bessen D, Fischetti VA.

J Exp Med. 1988 Jun 1;167(6):1945-50.

PMID:
3290383
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Vaccination equally enables both genetically susceptible and resistant mice to control infection with group A streptococci.

Siegert J, Sastalla I, Chhatwal GS, Medina E.

Microbes Infect. 2006 Feb;8(2):347-53. Epub 2005 Sep 13.

PMID:
16213175
[PubMed - indexed for MEDLINE]
19.

A randomized trial of conjugated group B streptococcal type Ia vaccine in a rabbit model of ascending infection.

Davies JK, Paoletti LC, McDuffie RS, Madoff LC, Lee S, Eskens J, Gibbs RS.

Am J Obstet Gynecol. 1999 Oct;181(4):803-8.

PMID:
10521733
[PubMed - indexed for MEDLINE]
20.

Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.

Mannam P, Jones KF, Geller BL.

Infect Immun. 2004 Jun;72(6):3444-50.

PMID:
15155651
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk